Consolidated Statements of Income (USD $)	3 Months Ended		9 Months Ended
	Jul. 31, 2012	Jul. 31, 2011	Jul. 31, 2012	Jul. 31, 2011
Revenues	$ 2,946,865	$ 3,332,814	$ 9,942,653	$ 10,207,901
Cost of revenues	1,403,923	1,502,765	4,583,324	4,477,047
Research and development	144,080	175,537	357,412	327,012
Selling, general, and administrative expenses	1,158,739	1,386,728	3,670,603	4,004,265
Total costs and expenses	2,706,742	3,065,030	8,611,339	8,808,324
Income from operations	240,123	267,784	1,331,314	1,399,577
Interest expense - related party	73,828	133,243	219,880	823,807
Income before income taxes	166,295	134,541	1,111,434	575,770
Provision for income taxes	10,125	7,565	15,771	17,128
Net income	$ 156,170	$ 126,976	$ 1,095,663	$ 558,642
Net income per common share - basic	$ 0.02	$ 0.02	$ 0.15	$ 0.10
Net income per common share - diluted	$ 0.02	$ 0.02	$ 0.14	$ 0.09
Weighted average number of common shares outstanding - basic	7,193,140	6,945,036	7,182,169	5,463,353
Weighted average number of common shares outstanding - diluted	8,018,570	7,782,608	8,011,755	6,262,776